Press Releases :: Codexis, Inc. (CDXS)

Access our TIDES USA 2025 Investor Recap Call

View Replay

Year

Category

Feb 26, 2019 4:05 pm EST

Codexis Reports 2018 Fourth Quarter and Full Year Financial Results

Feb 25, 2019 7:00 am EST

Codexis Names Laurie Heilmann Senior Vice President of Business Development and Marketing

Feb 19, 2019 7:00 am EST

Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26

Feb 14, 2019 7:00 am EST

Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria

Feb 6, 2019 7:00 am EST

Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan

Feb 4, 2019 4:05 pm EST

Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck

Nov 8, 2018 4:05 pm EST

Codexis Reports Third Quarter 2018 Financial Results

Nov 8, 2018 7:00 am EST

Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114

Nov 7, 2018 4:05 pm EST

Codexis to Present at Two Investment Conferences in November

Nov 1, 2018 7:00 am EDT

Codexis to Hold Third Quarter 2018 Conference Call on November 8